Back
CRISPR Therapeutics AG Stock Price Chart
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
33
CRSP
CRISPR Therapeutics AG
Last Price:
$40.01
Seasonality Move:
10.95%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRISPR Therapeutics AG Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.69 | Sell |
| 20-day SMA: | 46.52 | Sell |
| 50-day SMA: | 47.96 | Sell |
| 200-day SMA: | 53.42 | Sell |
| 8-day EMA: | 42.05 | Sell |
| 20-day EMA: | 44.76 | Sell |
| 50-day EMA: | 46.95 | Sell |
| 200-day EMA: | 51.94 | Sell |
CRISPR Therapeutics AG Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.34 | Sell |
| Relative Strength Index (14 RSI): | 35.67 | Sell |
| Chaikin Money Flow: | 683795 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.59 - 51.13) | Sell |
| Bollinger Bands (100): | (44.82 - 50.32) | Sell |
CRISPR Therapeutics AG Technical Analysis
| Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CRISPR Therapeutics AG Stock
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 41.07 while CRSP 8-day simple moving average is 41.69, which is a Sell signal.
-
The stock price of CRSP is 41.07 while CRISPR Therapeutics AG 20-day SMA is 46.52, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day simple moving average is 47.96 while CRSP share price is 41.07, making it a Sell technically.
-
CRSP stock price is 41.07 and CRISPR Therapeutics AG 200-day simple moving average is 53.42, creating a Sell signal.
CRSP Technical Analysis vs Fundamental Analysis
Sell
33
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy or a Sell?
-
CRISPR Therapeutics AG stock is rated a SellThe current CRISPR Therapeutics AG [CRSP] share price is $41.07. The Score for CRSP is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
CRISPR Therapeutics AG Stock Info
Market Cap:
3.5B
Price in USD:
41.07
Share Volume:
1.1M
CRISPR Therapeutics AG 52-Week Range
52-Week High:
91.10
52-Week Low:
39.41
Sell
33
CRISPR Therapeutics AG (CRSP)
is a Sell
CRISPR Therapeutics AG Share Price Forecast
-
What is the CRISPR Therapeutics AG stock price today?The CRISPR Therapeutics AG stock price is 41.07 USD today.
-
Will CRSP stock go up or go down?CRISPR Therapeutics AG> share price is forecast to RISE/FALL based on technical indicators
-
Is CRISPR Therapeutics AG overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CRISPR Therapeutics AG is overvalued.
Is CRISPR Therapeutics AG Stock a Buy?
-
CRISPR Therapeutics AG share price is 41.07 while CRSP 8-day exponential moving average is 42.05, which is a Sell signal.
-
The stock price of CRSP is 41.07 while CRISPR Therapeutics AG 20-day EMA is 44.76, which makes it a Sell.
-
CRISPR Therapeutics AG 50-day exponential moving average is 46.95 while CRSP share price is 41.07, making it a Sell technically.
-
CRSP stock price is 41.07 and CRISPR Therapeutics AG 200-day simple moving average is 51.94, creating a Sell signal.
Fundamental Analysis of CRISPR Therapeutics AG
Is CRISPR Therapeutics AG a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.20 per share, and an increase next year of $0.14 per share.
Technical Analysis of CRISPR Therapeutics AG
Should I short CRISPR Therapeutics AG stock?
-
CRSP Moving Average Covergence Divergence (MACD) indicator is -2.34, suggesting CRISPR Therapeutics AG is a Sell
-
CRISPR Therapeutics AG Relative Strength Index (RSI) is 35.67, which suggest CRISPR Therapeutics AG is oversold
-
The Bollinger Bands (25) for CRISPR Therapeutics AG is (42.59 - 51.13), which suggest CRISPR Therapeutics AG is a Sell
-
The Bollinger Bands (100) for CRISPR Therapeutics AG is (44.82 - 50.32), which suggest CRISPR Therapeutics AG is a Sell
* CRISPR Therapeutics AG stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.